Report overview
The global Radiology Drug Therapy market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Oncology Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Radiology Drug Therapy include Nihon Medi-Physics, ITM Isotopen Technologien M?nchen AG, Advanced Accelerator Applications, Telix Pharmaceuticals, GE Healthcare, Theragnostics Ltd., NuView Life Sciences, Jubilant Pharma Limited and Lantheus Holdings, Inc., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Nuclear medicine therapy uses radiopharmaceuticals targeting specific tumors, such as thyroid tumors, lymphomas, or bone metastases, to deliver radiation to neoplastic lesions as part of a therapeutic strategy to cure, alleviate, or control the disease.
This report aims to provide a comprehensive presentation of the global market for Radiology Drug Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiology Drug Therapy. This report contains market size and forecasts of Radiology Drug Therapy in global, including the following market information:
Global Radiology Drug Therapy Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Radiology Drug Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Radiology Drug Therapy Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Radiology Drug Therapy Market Segment Percentages, by Type, 2023 (%)
Oncology
Cardiology
Others
Global Radiology Drug Therapy Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Radiology Drug Therapy Market Segment Percentages, by Application, 2023 (%)
Hospitals
Academic & Research Institutes
Others
Global Radiology Drug Therapy Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Radiology Drug Therapy Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Radiology Drug Therapy revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Radiology Drug Therapy revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nihon Medi-Physics
ITM Isotopen Technologien M?nchen AG
Advanced Accelerator Applications
Telix Pharmaceuticals
GE Healthcare
Theragnostics Ltd.
NuView Life Sciences
Jubilant Pharma Limited
Lantheus Holdings, Inc.
Curium Pharma
Bayer AG
Clarity Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Radiology Drug Therapy, market overview.
Chapter 2: Global Radiology Drug Therapy market size in revenue.
Chapter 3: Detailed analysis of Radiology Drug Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Radiology Drug Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
